EP3664829 - PD-1 AND PD-L1 BINDING AGENTS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 23.09.2022 Database last updated on 06.11.2024 | |
Former | Request for examination was made Status updated on 15.05.2020 | ||
Former | The international publication has been made Status updated on 16.02.2019 | Most recent event Tooltip | 14.09.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states Orionis Biosciences, Inc. 275 Grove Street Newton, MA 02466 / US | For all designated states Orionis Biosciences BV Technologiepark 94 9052 Ghent / BE | [2020/45] |
Former [2020/25] | For all designated states Orionis Biosciences, Inc. 275 Grove Street Newton, MA 02466 / US | ||
For all designated states Orionis Biosciences NV Rijvisschestraat 120 9052 Zwijnaarde / BE | Inventor(s) | 01 /
KLEY, Nikolai c/o Orionis Biosciences Inc. 275 Grove Street Newton, MA 02466 / US | 02 /
TAVERNIER, Jan Bottelweg 2 B-9860 Balegem / BE | 03 /
ZABEAU, Lennart c/o Orionis Biosciences NV Rijvisschestraat 120 B-9052 Zwinjnaarde / BE | 04 /
DEPLA, Erik c/o Orionis Biosciences NV Rijvisschestraat 120 B-9052 Zwinjnaarde / BE | [2020/25] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
Former [2020/25] | Gibson, Mark Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | Application number, filing date | 18844220.6 | 08.08.2018 | [2020/25] | WO2018US45743 | Priority number, date | US201762542921P | 09.08.2017 Original published format: US 201762542921 P | [2020/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019032663 | Date: | 14.02.2019 | Language: | EN | [2019/07] | Type: | A1 Application with search report | No.: | EP3664829 | Date: | 17.06.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.02.2019 takes the place of the publication of the European patent application. | [2020/25] | Search report(s) | International search report - published on: | US | 14.02.2019 | (Supplementary) European search report - dispatched on: | EP | 06.04.2021 | Classification | IPC: | A61K38/00, A61K38/19, A61K39/00, C07K14/52, C07K16/28 | [2020/25] | CPC: |
C07K14/70532 (EP);
C07K16/2827 (EP,US);
A61P35/00 (US);
C07K14/525 (EP);
C07K14/54 (EP);
C07K14/555 (EP);
C07K14/56 (EP,US);
C07K14/565 (US);
C07K16/2818 (EP);
A61K2039/505 (US);
A61K38/00 (EP);
C07K2317/21 (US);
C07K2317/33 (EP);
C07K2317/565 (US);
C07K2317/569 (EP,US);
C07K2317/76 (US);
C07K2317/92 (EP);
C07K2319/02 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/25] | Title | German: | PD-1- UND PD-L1-BINDEMITTEL | [2020/25] | English: | PD-1 AND PD-L1 BINDING AGENTS | [2020/25] | French: | AGENTS DE LIAISON À PD-1 ET PD-L1 | [2020/25] | Entry into regional phase | 24.02.2020 | National basic fee paid | 24.02.2020 | Search fee paid | 24.02.2020 | Designation fee(s) paid | 24.02.2020 | Examination fee paid | Examination procedure | 24.02.2020 | Examination requested [2020/25] | 02.11.2021 | Amendment by applicant (claims and/or description) | 27.09.2022 | Despatch of a communication from the examining division (Time limit: M06) | 06.04.2023 | Reply to a communication from the examining division | 31.07.2023 | Despatch of a communication from the examining division (Time limit: M06) | 08.02.2024 | Reply to a communication from the examining division | 27.05.2024 | Despatch of a communication from the examining division (Time limit: M06) | Fees paid | Renewal fee | 20.08.2020 | Renewal fee patent year 03 | 24.08.2021 | Renewal fee patent year 04 | 25.08.2022 | Renewal fee patent year 05 | 25.08.2023 | Renewal fee patent year 06 | 27.08.2024 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2017077382 (ORIONIS BIOSCIENCES NV [BE], et al); | [E]WO2018077893 (ORIONIS BIOSCIENCES NV [BE], et al); | International search | [A]US8993731 (TYSON KERRY LOUISE [GB]); | [A]WO2015048520 (GENENTECH INC [US], et al); | [A]US2016108123 (FREEMAN GORDON JAMES [US], et al); | [A]WO2016061142 (NOVARTIS AG [CH], et al); | [A]WO2016092419 (RINAT NEUROSCIENCE CORP [US]); | [X]WO2017077382 (ORIONIS BIOSCIENCES NV [BE], et al) | Examination | WO2007005874 | WO2008071447 |